145.40
-0.60
(-0.41%)
At close: January 29 at 4:35:18 PM GMT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-105,917.00
-105,917.00
-178,792.00
-158,274.00
-131,827.00
Investing Cash Flow
68,991.00
68,991.00
-107,223.00
197,375.00
364,478.00
Financing Cash Flow
78,141.00
78,141.00
-29,827.00
22,727.00
38,869.00
End Cash Position
191,081.00
191,081.00
149,866.00
465,708.00
403,881.00
Capital Expenditure
-245.00
-245.00
-2,176.00
-5,661.00
-5,424.00
Issuance of Capital Stock
1,153.00
1,153.00
332.00
-12,979.00
-11,760.00
Issuance of Debt
--
--
393.00
2,215.00
39,788.00
Repurchase of Capital Stock
-19,650.00
-19,650.00
-26,492.00
--
--
Free Cash Flow
-106,162.00
-106,162.00
-180,968.00
-163,935.00
-137,251.00
12/31/2020 - 6/19/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HEMO.L Hemogenyx Pharmaceuticals Plc
362.50
+1.40%
OPORF hVIVO plc
0.2900
0.00%
OBD.L Oxford BioDynamics Plc
0.6500
+30.00%
VAL.L ValiRx plc
0.7750
-3.13%
ABVX.PA ABIVAX Société Anonyme
5.87
-1.18%
SCLP.L Scancell Holdings plc
9.66
-0.92%
NXTC NextCure, Inc.
0.7992
0.00%
GLTO Galecto, Inc.
5.10
-3.87%
PHVS Pharvaris N.V.
17.64
-2.00%
HNSA.ST Hansa Biopharma AB (publ)
31.66
-1.92%